Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 19/20 | 0.66 |
| ▸ | NPY1R | P25929 | 12/20 | 0.66 |
| ▸ | NPY5R | Q15761 | 10/20 | 0.66 |
| ▸ | NPY2R | P49146 | 8/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29376626 | 0.99 | NPY4R (0.67) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL30385910 | 0.94 | NPY4R (0.66) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL30386233 | 0.94 | NPY4R (0.66) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL30334190 | 0.94 | NPY4R (0.73) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL30153268 | 0.93 | NPY4R (0.65) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL31679394 | 0.93 | NPY4R (0.59) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL30731371 | 0.92 | NPY4R (0.55) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL13563452 | 0.92 | NPY4R (0.67) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL18951657 | 0.92 | NPY4R (0.67) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL30688833 | 0.92 | NPY4R (0.61) | NPY4RNPY1RNPY5RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260015399-A1 | SOLUBLE NPY2 RECEPTOR AGONISTS | BOEHRINGER INGELHEIM INT (DE) | 2026-01-15 | — | — | US | claimed |
| EP-4192853-A1 | SOLUBLE NPY2 RECEPTOR AGONISTS | Boehringer Ingelheim International GmbH (DE) | 2023-06-14 | — | — | EP | claimed |
| CN-116171282-A | Soluble NPY2 receptor agonists | 勃林格殷格翰国际有限公司 | 2023-05-26 | — | — | CN | claimed |
| US-20220041678-A1 | SOLUBLE NPY2 RECEPTOR AGONISTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2022-02-10 | — | — | US | claimed |
| WO-2022029231-A1 | SOLUBLE NPY2 RECEPTOR AGONISTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2022-02-10 | — | — | WO | claimed |
| CN-122071508-A | Targeting NPY polypeptide nuclide ligand and preparation method and application thereof | 中国科学院宁波材料技术与工程研究所 | 2026-05-22 | — | — | CN | disclosed |
| US-20260015399-A1 | SOLUBLE NPY2 RECEPTOR AGONISTS | BOEHRINGER INGELHEIM INT (DE) | 2026-01-15 | — | — | US | disclosed |
| US-12391737-B2 | Soluble NPY2 receptor agonists | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2025-08-19 | — | — | US | disclosed |
| EP-4192853-A1 | SOLUBLE NPY2 RECEPTOR AGONISTS | Boehringer Ingelheim International GmbH (DE) | 2023-06-14 | — | — | EP | disclosed |
| CN-116171282-A | Soluble NPY2 receptor agonists | 勃林格殷格翰国际有限公司 | 2023-05-26 | — | — | CN | disclosed |
| US-20220041678-A1 | SOLUBLE NPY2 RECEPTOR AGONISTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2022-02-10 | — | — | US | disclosed |
| WO-2022029231-A1 | SOLUBLE NPY2 RECEPTOR AGONISTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2022-02-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220041678-A1 | SOLUBLE NPY2 RECEPTOR AGONISTS | NPY2R, NPY1R, NPY5R | NPY4R 4/4885NPY1R 2/4885NPY5R 3/4885 |
| US-12391737-B2 | Soluble NPY2 receptor agonists | NPY2R, NPY1R, NPY5R | NPY4R 4/4885NPY1R 2/4885NPY5R 3/4885 |
| US-20260015399-A1 | SOLUBLE NPY2 RECEPTOR AGONISTS | NPY1R, NPY2R, NPY5R | NPY4R 4/4885NPY1R 1/4885NPY5R 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.